Emergency, Prehospital & Humanitarian
Time-critical oxygen delivery where blood logistics, geography and access can constrain emergency resuscitation.
BHOC Therapeutics — Precision Oxygenation Therapeutics
The Science
From oxygen in the lungs to oxygen at the cell.
Effective oxygen delivery depends on more than a hemoglobin number. Oxygen loading, blood flow, hemoglobin oxygen affinity, microcirculation, unloading, diffusion and tissue demand all influence whether sufficient oxygen ultimately reaches the cell.
Lungs→Hemoglobin→Circulation→Microcirculation→Tissue→Cell→Mitochondria
The Technology
Biological Hemoglobin Oxygen Carriers
BHOC — Biological Hemoglobin Oxygen Carrier — describes a platform approach centered on hemoglobin-mediated oxygen transport outside the conventional red-cell framework.
The broader scientific field includes HBOCs, historical products such as Oxyglobin and Hemopure, and emerging oxygen-carrier technologies. These technologies differ substantially in source, molecular architecture, oxygen affinity, circulation characteristics, oxidation profile, storage and intended clinical use.
Where Oxygen Delivery Matters
Oxygen-critical clinical environments
BHOC Therapeutics is building a scientific and development framework around conditions in which oxygen delivery can become a central clinical problem. These areas are presented as fields of scientific and development interest, not as approved therapeutic claims.
Acute & Severe Anemia
Conditions in which blood oxygen-carrying capacity is critically reduced or compatible blood is unavailable.
Surgery, PPH & Bloodless Resuscitation
Surgical blood loss, postpartum hemorrhage and care pathways where transfusion may be delayed or not an option.
Organ Transplantation, Perfusion & Preservation
Kidney, liver and heart environments where oxygenated perfusion and organ preservation influence graft viability.
Ischemia, Hypoxia & Cardiac Emergencies
Scientific context for impaired oxygen delivery in ischemia, hypoxia, myocardial infarction and cardiac arrest.
Sickle Cell Disease & Sickle Cell Anemia
Research context for oxygen delivery, severe anemia and transfusion support in SCD and SCA.
Veterinary Medicine
Scientific, clinical and regulatory evidence from veterinary oxygen-carrier use.
Remote & Resource-Limited Care
Oxygen-delivery options for austere, disaster, battlefield and low-resource healthcare environments.
The Direction
From oxygen carrying to Precision Oxygenation Therapeutics.
WHEREWhere is oxygen needed?
WHENWhen is delivery inadequate?
HOWWhat oxygen-delivery profile is required?
Evidence
Evidence before claims.
BHOC Therapeutics is organizing scientific, clinical, veterinary, preclinical, regulatory and historical evidence so that important statements can be traced back to their source and context.
Field Context
Oxygen-carrier science in context
This site documents the evolution from artificial-blood research and blood substitutes to HBOCs, BHOCs, oxygen therapeutics and precision oxygenation. Historical materials are presented for scientific context and do not imply commercial affiliation.
Historical Perspective
Standing on the Shoulders of Giants
Biopure and the People Behind an Early Oxygen-Therapeutics Platform — a source-based historical perspective on the people, industrial capabilities and institutional network behind an early oxygen-therapeutics platform.
Read the historical perspective ↗BHOC Therapeutics
Building the next chapter of oxygen-delivery science.
Our focus is to connect physiology, technology, evidence and clinical need into a disciplined framework for Precision Oxygenation Therapeutics.